Yucca vs MEDVi vs Synergy Rx 2026: Which Compounded GLP-1 Wins?

The 10-second verdict

• Cheapest steady-state price: Yucca Health — ~$196/mo average on the 6-month plan ($146 promo month 1, then $206). Flat at every dose.
• Best clinical bundle for beginners: MEDVi — $179 first month then $299/mo, injectable AND oral formats, labs + dietitian included via a 600+ clinician network.
• Best support + format range: Synergy Rx — ~$199/mo, oral dissolving tablets for both molecules, 24/7 support, tightest follow-up cadence.

But if your decision is purely about price, two providers beat all three: Embody and SnagRx both sit at $69/mo semaglutide on 12-month plans. This comparison matters because Yucca, MEDVi, and Synergy are the three most-searched names in the mid-price tier — here's who each one actually serves best.

Head-to-head: September 2026 verified

Yucca Health — the budget pick ($146/mo)

Yucca (tryyucca.com, Beverly Hills, CA) is the cheapest verified steady-state compounded semaglutide on the market. Competitors advertise $99–$119 teasers that jump to $199+ after month one; Yucca's $146 is the durable rate — and it's flat.

Two named board-certified physicians handle prescribing — Dr. Michael Wasef, MD and Dr. Andrew Sakla, DO — which is rare accountability in compounded GLP-1. Approval is async (24h, no scheduled call), shipping is UPS 2-day, and Klarna/Affirm/Afterpay spread the 6-month commitment. With 20,000+ patients and ~4.6★ across 1,200+ Trustpilot reviews, Yucca has the deepest verified review base in this comparison.

Trade-offs: injectable only, compounded only, and the $146 rate requires the 6-month plan — month-to-month costs meaningfully more.

MEDVi — the beginner pick ($179 intro → $299/mo)

MEDVi sells the smoothest onboarding in the category — eligibility quiz, guided intake, no video visit, 600+ clinicians via OpenLoop — plus metabolic lab panels, a free dietitian visit, and care coaching in the base price. The catch is pricing structure: $179 is the first-month intro rate only; ongoing refills are $299/mo ($399 tirzepatide; +$70/mo for oral tablets). Month-to-month, cancel anytime, no contract.

Trade-offs: at $299 ongoing it costs roughly double the market floor for the same compounded molecule — the premium buys labs, coaching, and dietitian access. BBB complaints cite billing and refund friction, and its oral semaglutide is compounded tablets — not the FDA-approved Wegovy pill. Full details: MEDVi review.

Synergy Rx — the support pick (~$199/mo)

Synergy Rx is the most expensive of the three — deliberately. It's the only one offering oral dissolving tablets for both semaglutide AND tirzepatide, making it the strongest needle-free option short of the FDA-approved pill. Check-ins are more frequent, support runs 24/7, and pharmacy fulfillment reliability is better-reviewed than cheaper compounded platforms.

Trade-offs: the ~$54/mo premium over Yucca adds up to ~$648/year. Its operator registers at a Casper, WY address with a thinner independent review footprint — verify pharmacy partners and provider credentials before enrolling. And its brand-name pricing ($499–$947/mo) is far above NovoCare and LillyDirect direct pricing — don't use it for brand drugs.

Decision by buyer type

Bottom line

For most buyers comparing these three, Yucca Health wins on value — ~$196/mo ongoing average, flat at every dose, with named physicians and the strongest verified review base. MEDVi is worth its premium only if labs and dietitian access justify $299/mo ongoing. Synergy Rx justifies its $199 only if you need oral formats for both molecules. And if raw price is the only axis, the $69/mo tier (Embody, SnagRx) undercuts all three — compare everything in our GLP-1 Price Index.

Affiliate disclosure: This article contains affiliate links. We may earn a commission if you sign up through them, at no extra cost to you. Compounded GLP-1 medications are not FDA-approved as finished products and require a prescription. Pricing verified September 2026 — confirm current rates at checkout.